← Back to Clinical Trials
Recruiting NCT07915830

NCT07915830 Comparing Two Laparoscopic Techniques for Hernia Repair in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07915830
Status Recruiting
Phase —
Sponsor Quaid-e-Azam Medical College
Condition Inguinal Hernia
Study Type INTERVENTIONAL
Enrollment 412 participants
Start Date 2026-05-12
Primary Completion 2026-11-11

Eligibility & Interventions

Sex All sexes
Min Age 1 Year
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Laparoscopic Percutaneous Extraperitoneal Closure (LPEC)Laparoscopic Intracorporeal Suture (LIS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 412 participants in total. It began in 2026-05-12 with a primary completion date of 2026-11-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this randomized controlled trial is to compare the outcomes of two laparoscopic techniques for repairing inguinal hernia in children: laparoscopic percutaneous extraperitoneal closure (LPEC) and laparoscopic intracorporeal suture (LIS). The study will be conducted in the Department of Pediatric Surgery, Bahawal Victoria Hospital, Bahawalpur, and will enroll children aged 1 to 15 years of either gender who have a unilateral or bilateral inguinal hernia and are planned for laparoscopic repair. Children with recurrent, incarcerated, or previously operated hernias, coagulopathy, undescended testes, major congenital abdominal anomalies, congenital heart disease, or cerebral palsy will be excluded. Participants will be randomly assigned, using sealed opaque envelopes, to one of two groups. Group A will undergo LPEC, in which the hernia sac is closed extraperitoneally with a needle passed percutaneously around the internal inguinal ring under laparoscopic view. Group B will undergo LIS, in which sutures are placed and tied entirely within the abdominal cavity. All operations will be performed by a single surgical team trained in both techniques. The main outcome is hernia recurrence at 3 months. Secondary outcomes are operating time, post-operative pain (FLACC score at 12 hours, assessed by a resident blinded to the technique), hospital stay, wound infection within 30 days, other intra- and post-operative complications, and time to return to full activity. Children will be followed weekly in the outpatient clinic and assessed for recurrence at 3 months. The study hypothesizes that recurrence at 3 months is higher with the intraperitoneal (LIS) approach than with the extraperitoneal (LPEC) approach.

Eligibility Criteria

Inclusion Criteria: * unilateral or bilateral inguinal hernia * planned to undergo laparoscopic hernia repair Exclusion Criteria: * recurrent hernia * hernia after previous abdominal surgery * incarcerated hernia * coagulopathy * Associated undescended testes * Major congenital abdominal anomalies * Children with congenital heart disease * Cerebral palsy.

Contact & Investigator

Central Contact

Fatima A Principal Investigator, MBBS

✉ iffat.fatima47@gmail.com

📞 +92 321 6381440

Principal Investigator

Muhammad R Professor, FCPS

STUDY CHAIR

Quaid-e-Azam Medical College

Frequently Asked Questions

Who can join the NCT07915830 clinical trial?

This trial is open to participants of all sexes, aged 1 Year or older, up to 15 Years, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07915830 currently recruiting?

Yes, NCT07915830 is actively recruiting participants. Contact the research team at iffat.fatima47@gmail.com for enrollment information.

Where is the NCT07915830 trial being conducted?

This trial is being conducted at Bahawalpur, Pakistan.

Who is sponsoring the NCT07915830 clinical trial?

NCT07915830 is sponsored by Quaid-e-Azam Medical College. The principal investigator is Muhammad R Professor, FCPS at Quaid-e-Azam Medical College. The trial plans to enroll 412 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology